Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | METAP1 | P53582 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | TDP2 | O95551 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorene SCHEMBL15453329 | 0.98 | ALDH1A1 (0.59) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL415882 | 0.98 | ALDH1A1 (0.59) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL29780658 | 0.98 | ALDH1A1 (0.59) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL29466104 | 0.98 | ALDH1A1 (0.59) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL17313627 | 0.92 | SMN1; SMN2 (0.53) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL23542831 | 0.89 | L3MBTL1 (0.56) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL19237245 | 0.89 | L3MBTL1 (0.56) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL1806266 | 0.89 | L3MBTL1 (0.56) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| Ammonia Solution, Strong SCHEMBL28144371 | 0.89 | METAP1 (0.55) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 | |
| SCHEMBL29376113 | 0.87 | METAP1 (0.57) | ALDH1A1RAB9ASMN1; SMN2KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8419808-B2 | Dye compound and photoelectric component using the same | EVERLIGHT USA, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-8203068-B2 | Dye compound and photoelectric component using the same | EVERLIGHT USA, INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-20120042457-A1 | DYE COMPOUND AND PHOTOELECTRIC COMPONENT USING THE SAME | EVERLIGHT USA, INC. (US) | 2012-02-23 | — | — | US | disclosed |
| US-20110100462-A1 | Dye-sensitized solar cell and photoanode thereof | EVERLIGHT USA, INC. (US) | 2011-05-05 | — | — | US | disclosed |
| US-20100122729-A1 | Dye compound and photoelectric component using the same | EVERLIGHT USA, INC. (US) | 2010-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120042457-A1 | DYE COMPOUND AND PHOTOELECTRIC COMPONENT USING THE SAME | CRY1, SCNN1B, SMARCC2 | ALDH1A1 491/4885RAB9A 1440/4885SMN1; SMN2 3352/4885 |
| US-20100122729-A1 | Dye compound and photoelectric component using the same | CRY1, SCNN1B, SMARCC2 | ALDH1A1 491/4885RAB9A 1440/4885SMN1; SMN2 3352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.